BTI
WST icon

Blue Trust Inc’s West Pharmaceutical WST Stock Holding History

Blue Trust Inc’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98K Sell
273
-6
-2% -$1.83K ﹤0.01% 1057
2026
Q1 		$69.9K Sell
279
-12
-4% -$2.99K ﹤0.01% 1184
2025
Q4 		$80.1K Buy
291
+7
+2% +$1.92K ﹤0.01% 1166
2025
Q3 		$74.5K Sell
284
-5
-2% -$1.22K ﹤0.01% 1207
2025
Q2 		$63.2K Buy
289
+103
+55% +$22K ﹤0.01% 1262
2025
Q1 		$41.6K Buy
186
+22
+13% +$6.06K ﹤0.01% 1446
2024
Q4 		$53.7K Sell
164
-655
-80% -$206K ﹤0.01% 1275
2024
Q3 		$270K Buy
819
+577
+238% +$177K ﹤0.01% 723
2024
Q2 		$95.8K Buy
242
+186
+332% +$65.7K ﹤0.01% 999
2024
Q1 		$22.2K Sell
56
-10
-15% -$3.7K ﹤0.01% 1192
2023
Q4 		$24K Buy
66
+61
+1,220% +$21.6K ﹤0.01% 1217
2023
Q3 		$2K Sell
5
-4
-44% -$1.55K ﹤0.01% 1865
2023
Q2 		$3K Sell
9
-18
-67% -$6.43K ﹤0.01% 1690
2023
Q1 		$7K Sell
27
-16
-37% -$4.67K ﹤0.01% 1717
2022
Q4 		$11K Buy
43
+27
+169% +$6.4K ﹤0.01% 1524
2022
Q3 		$5K Sell
16
-3
-16% -$914 ﹤0.01% 1594
2022
Q2 		$8K Buy
+19
New +$6.18K ﹤0.01% 1308

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Blue Trust Inc's WST Position: Q2 2026 in Review

Blue Trust Inc reduced its West Pharmaceutical (WST) stake by 2.2% in Q2 2026, selling an estimated $1.83K and leaving 273 shares worth $98K. The position accounts for ﹤0.01% of the portfolio, ranked #1057.

Blue Trust Inc first reported a position in WST in Q2 2022 and has held it in 17 quarters since. The position peaked at $270K in Q3 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Blue Trust Inc held 273 shares of West Pharmaceutical worth $98K as of Q2 2026.
  • Blue Trust Inc sold 6 West Pharmaceutical shares in Q2 2026, an estimated $1.83K.
  • West Pharmaceutical made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1057 holding.
  • Blue Trust Inc first reported a position in West Pharmaceutical in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's West Pharmaceutical position peaked at $270K in Q3 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.